A study published in Science of the Total Environment sheds light on the persistent chemical contaminants left behind at ...
Reddit's popularity as a tool for self-managing inflammatory bowel disease highlights opportunities for improvements in ...
The U.S. Food and Drug Administration on Wednesday cleared Regeneron Pharmaceuticals’ immunotherapy, Libtayo, as an add-on treatment for skin cancer patients at high risk of their disease returning ...
A once-daily pill for ulcerative colitis has delivered strong results in a clinical trial, easing symptoms even in patients ...
The FDA has approved Jascayd (nerandomilast) tablets to treat idiopathic pulmonary fibrosis, a rare, progressive lung disease that can cause scarring ...
Cemiplimab (Libtayo; Regeneron Pharmaceuticals) has been approved as an adjuvant treatment for adult patients with cutaneous ...
A new report reveals widespread pesticide residues in the host plants of pollinators found in urban green spaces in ...
The FDA approved Boehringer's nerandomilast, now Jascayd, as the first new U.S. treatment for idiopathic pulmonary fibrosis ...